ParaZero Taps Pfizer Veteran Bat-Sheva Noy as VP of Global Sales
Event summary
- Bat-Sheva Noy appointed VP of Global Sales at ParaZero Technologies, effective March 2026.
- Noy brings 20+ years of commercial leadership experience, most recently as Business Unit Lead for Rare Diseases at Pfizer Israel (2020-2025).
- ParaZero aims to leverage Noy's expertise in strategic planning and market access to expand its global commercial presence in drone safety and aerospace.
- Noy holds dual degrees in Law and Chemistry/Biology from Israeli institutions, with prior military service in the IDF.
The big picture
ParaZero's appointment of Bat-Sheva Noy signals a strategic pivot towards leveraging pharmaceutical industry expertise to drive growth in the aerospace and drone safety sectors. The move comes as the global UAS market continues to expand, with increasing demand for autonomous solutions that enhance safety and regulatory compliance. Noy's background in strategic planning and market access could be pivotal in navigating this competitive landscape.
What we're watching
- Market Expansion Strategy
- How Noy's pharmaceutical industry experience will translate to ParaZero's aerospace and drone safety market.
- Cross-Functional Leadership
- Whether Noy can effectively lead cross-functional teams in a sector different from her prior pharmaceutical focus.
- Global Sales Growth
- The pace at which ParaZero can scale its commercial presence under Noy's leadership.